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Human Dendritic Cell Differentiation Pathway From 0 3 4 ' Hematopoietic Precursor Cells
By Michelle Rosenzwajg, Bruno Canque, and Jean Claude Gluckman
The most effective antigen-presenting cells for T lymphocytes are dendritic cells (DCs), the differentiation pathway of which, however, is incompletely characterized. We examined here how DCs differentiated from human cord blood CD34+ progenitor cells cultured with granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-a, and stem cell factor. After 5 days, 2 of 3 nonadherent cells were CD13hiHLA-DRhiCD4f, half of them were also CD14+, and 510% were CDla'. When day-5 sorted CD13h'CDla-and CD13" cells were further cultured, CDla+ cells appeared in the already CD13hi population, whereas CD13hi cells, a minority of which rapidly became CDla+, emerged from the CDl3l0 population. By day 12, still 66% of bulk cells in suspension were CD13h', most of which displayed high forward and side scatters of large granular cells. Half of CD13hi cells were CDla+. All CD13hi cells expressed t o the same extent DR, ENDRITIC CELLS (DCs) are the most potent antigenpresenting cells (APCS).'~ Only they can prime naive T-helper lymphocytes, whereas macrophages or activated B cells stimulate only primed ~e l l s ' ,~-~ and also can elicit cytotoxic T lymphocyte responses to soluble antigens.'-'' DCs are present in most tissues, in which they display different maturation states according to the local microenvironment3; eg, they are known as Langerhans cells (LCs) in the skin, as interdigitating cells in lymphoid tissues, and as veiled cells in the lymph and blood.',"
Characterization of DCs in humans has been confounded both by the lack of exclusive lineage-specific markers and by their low numbers and consequent difficult isolation as pure populations; eg, they represent 5 1 % of mononuclear cells (MNCs) in the readily accessible peripheral tern appears from recent studies of different, mainly bloodderived and skin DC population^^^'^^'^"^: (1) the dendritic morphology, ( 2 ) the low phagocytic activity, (3) the high membrane density of HLA class I1 molecules and of accessory molecules, (4) the expression of CDla, and (5) the strong capacity to stimulate allogeneic T lymphocytes. 3 The differentiation pathway of this apparently heterogeneous cell population is still incompletely known in humans, and its lineage relationship with other bone marrow-derived cells, especially monocyte/macrophages, is questioned if only because the in vitro generation of mixed colonies of DCs, macrophages, and granulocytes from single CD34' hematopoietic precursors appears common. '8.19 The possibility to generate human DCs in vitro from bone marrow, cord blood, or even adult peripheral blood precursors '8-22 CD4, costimulatory and adhesion molecules, and various amounts of CD14. CDla+ cells stimulated allogeneic lymphocytes more than CD13hiCDla-cells and, although they were CD14+, both cell types were nonspecific esterase-negative nonphagocytic cells and were stronger mixed leukocyte reaction stimulators than were their macrophage counterparts. Eventually, the percentage of CDla+ cells decreased.
However, typical CDla' DCs still emerged in culture of sorted day-l2 CD13h%Dla-cells, and adding interleukin-4 t o bulk cultures at that time led to the persistence of the CDla' population while diminishing CD14 expression. Thus, this system resultsfirst in the differentiation of CD13h' precursors that strongly express DR and CD4, from which more mature CDla' DCs continuously differentiate all along the culture period. 0 1996 by The American Society of Hematology.
MATERIALS AND METHODS
Cord blood CD34' cell isolation and culture. Normal cord blood was obtained from Laboratoire Senders, hBpital Saint-Vincent de Paul (Paris, France), according to institutional guidelines. The cell suspension, diluted 1:l in RPM1 1640 (GIBCO BRL, Paisley, UK), was centrifuged on Ficoll-Paque (Pharmacia, Uppsala, Sweden). After washing in phosphate-buffered saline (PBS), 2% fetal calf serum (FCS; GIBCO B=), MNCs (I X 107/mL in PBS, 2% FCS) were incubated for 30 minutes at 4°C with 1:20 diluted fluorescein isothiocyanate (FITC)-labeled CD34 monoclonal antibody (MoAb) HPCA-2 (Becton Dickinson, Mountain View, CA), and CD34' cells were sorted by flow cytometry (FACStar Plus; Becton Dickinson) at 2,000 to 3,000 cellsls from a 5 X 10h/mL suspension. Gates were drawn on the two-color cytogram within a dual-parameter cytogram of side versus forward light scatter. Equations were set to positively sort cells satisfying both gates. This procedure yielded 94% t 3% pure viable CD34+ cells.
Alternatively, CD34+ cells were positively purified with CD34 MoAb 561-coated M450 Dynabeads (Dynal, Oslo, Norway), incubating 4 X IO' beads with 2.5 to 5 X IO7 cells/mL for 45 minutes at 4°C. Rosetted cells were seperated with a magnet, and beads were detached from the cells with DETACHaBEAD CD34 (Dynal) according to the manufacturer's instructions. This yielded 87% 5 13% pure viable CD34+ cells.
CD34+-enriched cells (2 to 5 X 104/mL) were cultured in 6-well 536 Table 1 . Negative controls were irrelevant MoAbs (Immunotech, Marseille, France).
For sorting, day-5 or day-l2 cultured cells ( 5 to 10 X 106/mL in PBS, 2% FCS) were washed, incubated at 4°C for 30 minutes with FITC-conjugated anti-CDla and PE-conjugated anti-CD13 MoAbs, and washed again. Cells were then sorted with the FACStar Plus according to both CD13 and CDla expression.
Immunocytochemical staining and other assays. Air-dried cytospin preparations were fixed for 5 minutes in 25% chlorofodacetone and kept at -70°C or they were fixed in PBS, 0.2% glutaraldehyde, and 1% formaldehyde and kept for few days at 4°C in PBS, 2% FCS. After thawing, slides were fixed again, air-dried, and rehydrated for 2 minutes with Tris-buffered saline (TBS), 0.5% bovine serum albumin (Sigma, St Louis, MO), 0.5% AB serum, 0.02% ROSENNVAJG, CANQUE, AND GLUCKMAN NP40, and 0.3% Hz02. After washing in TBS, slides were incubated for 2 hours at 20°C or overnight at 4°C with antibody. After two washes, slides were incubated for 45 minutes with 1:lOO diluted alcaline phosphatase-labeled antirabbit or peroxydase-labeled antimouse antibodies (Dako, Glostrup, Denmark) and then with Fast Red TR/Naphtol AS-MX or diaminobenzidine (Sigma). Reactions were stopped and slides were counterstained with Harris' hematoxilin (Sigma) and mounted. The MoAbs used were anti-CDla (L544, gift from L. Boumsell), anti-DR (Dako), BBl-B7 (Becton Dickinson), anti-CD40 (IOB40; Immunotech), and anti-S 100 (Dako).
Nonspecific esterase staining was performed using naphthyl-butyrate (Sigma) as substrate. To assay phagocytosis, cells were incubated with 1.16-p latex beads (Sigma) for 30 minutes at 37°C. After washing, cells were analyzed by light microscopy. Cells having ingested greater than 3 beads were scored as positive.
Mixed leukocyte reaction (MLR).
Ficoll-Paque-separated adult peripheral blood MNCs ( 5 X 104/100 pL) were cultured for 6 days in RPMI 1640, 10% FCS, 1% glutamine, and 1% antibiotics in 96-well U-bottomed culture microplates (Costar, Cambridge, MA) as responder cells to up to 1 X 104/100 pL 30-Gy irradiated stimulator cells, which were different populations of the CD34"derived cells.
['Hlthymidine (Amersham, Amersham, UK) incorporation was measured after an 8-hour pulse with l pCi/well. Results are shown as mean counts per minute (cpm) of triplicates.
RESULTS
Growth of cultured cells dlfferentiating from CD34+ precursors. In a first set of experiments, 5 X lo4 to 1.5 X 10' CD34+ cells purified from 0.9 to 4 X 10' cord blood MNCs were cultured in the presence of huGM-CSF and huTNF-(y. [18] [19] [20] This led to steadily increasing numbers of cells in suspension, which reached up to lo' on day 12 and plateaued or decreased thereafter. To increase yields, cells were also cultured with huSCF added to huGM-CSF and huTNF-a from the After 12 days, the cells had expanded 7-2 3-fold in the absence of huSCF relative to 45-2 27-fold when huSCF was present, without affecting the phenotype of the recovered cells or the proportion of DCs (data not shown). After 5 days, huSCF did not influence cell growth, and it could be discontinued. Unless otherwise stated, the data shown here were obtained with cells grown under the latter conditions.
As de~cribed,'~ either culture condition led to occurrence of small adherent aggregates with peripheral cells displaying typical DC morphology during the first 5 days of culture. Aggregate numbers increased and they enlarged until day 12, releasing DCs in the medium, while a few adherent macrophage-like cells also progressively appeared (data not shown).
Early phenotypic evolution of the cells in suspension. The bulk of initially purified CD34' cells were CD38' DR+CD13'"CD33'"CDla-; according to the MoAb, these cells appeared as CD4-(IOT4a) or CD4'" (Leu-3a, Leu3a+b; data not shown). 26 After 5 days, less than 10% CD34+ cells remained in culture. Two nonadherent cell populations were distinguished according to CD 13 expression; as averaged by quantitative analysis from seven different experiments, 32% 2 7% of cells were CD13'" and 65% 2 8% were CD13h' ( Fig  1A) . The CD13'" cells were CD4-CD14-CDla-, DR', or DR-; CD13h' cells were DRhiCD4'", with about 50% also use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From being CD14+ (Fig 1B) . There were then 9% ? 4% CDla+ cells, which were CD13hi, CD4+, DR+, CD14+ ( Fig 1C) ; they were CD38-, whereas the other cells were either CD38-or CD38+, with CD13" cells expressing more CD38 (Fig  IB and C) .
By day 12, two populations of cells in suspension were individualized according to size and granularity. One displayed low light scatter signals characteristic of small agranular cells (Rl: 75% ? 7% of cells; n = 13). The other had high scatter and autofluorescence signals of large granular cells (R2; Fig 2A) . Whereas all R2 cells were CD13hi and 75% ? 14% of them were CDla+, only 43% 2 14% of R1 cells were CD13hi, among which 8% ? 4% were CDla+. Altogether, whether large or small, CD13hi cells still represented 66% t 13% of the cells and half of them (36% 14%) were CDla+. All CD13h' cells expressed to the same extent CD4, DR, DQ, as well as adhesion molecules CD18, CD29, CD44, CD54 (ICAM-l), and CD58 (LFA-3) and costimulatory molecules CD40, CD80 (B7/BB1), and CD86 (B70/B7-2)*'; CD14 was present on these cells but its expression was variable, with some differences in intensity according to the MoAb used (My4 or LeuM3); CD13hi cells did not express CD15 (Fig 2B) .
All day-l2 cells were CD33+ but B-cell, T-cell, and NK cell markers (CD19, CD3, and CD56) were not detected (data not shown). CD13-"" cells (CD33+DR-CD4-CD14-C D W -) , which belonged to the granulocyte lineage, were found only among R1 cells (data not shown) and were not investigated further here.
Taken together, these findings suggest that, but for CDla expression, CD13hi labeling delineates a homogeneous population that should comprise the DC lineage.
Cytology of day 12 cells. Cells identified as DCs on cytospins either were large and round in shape with dendritic
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projections on the surface, abundant cytoplasm and reniform nuclei with dense chromatine and little nucleoli or were smaller with round nuclei but with the same other characteristics (Fig 3A) . This pattern could well correspond to R1 and R2 DCs. Most day-l2 CDla+ cells had a DC morphology, although CDla immunostaining was heterogeneous, whereas some CDla-cells had a DC morphology that was identical to that of the CDla+ cells (Fig 3A) . Cells with dendritic morphology were also stained by an LC-specific anti-S100 antibody (Fig 3B) .
Although they were CD14+, day-l2 cells with DC morphology were in fact myeloperoxidase-and nonspecific-esterase negative or weakly positive, whereas other cells, presumably of the macrophage lineage, were strongly positive; only less than 10% of the cells in suspension could phagocytose few latex particles in contrast to adherent cells of the same cultures, the majority of which displayed the macrophage lineage property to ingest numerous particles; the proportion of phagocytic cells increased to 25% on day 20, but these were still poorly phagocytic (data not shown).
Subsequent evolution of the cultured cells. This was primarily marked by a decrease of the percentage of CDla+ cells on day 20 relative to day 12 (Fig 4) . The phenotype of CD13hi cells was comparable to that of day 12 with respect to CD13, DR, and CD4 labeling, but the CD14 expression level was stronger then (data not shown).
Characterization of the in vitro DC dlfferentiation pathway. To more precisely characterize the phenotypic evolution of DCs in vitro, cultured cells were sorted by FACS according to CD13 and/or CDla expression.
First, sorting of CD13'" versus CD13hiCDla-cells, excluding those that already expressed CDla, was performed on day 5. Differentiation of cells of these distinct populations was then examined after further culture. Two days after sortuse only. ing, CDla+ cells appeared in the initially CD13hi population, mained CDla+ and CD14+ in culture, although some whereas CD13" cells, a minority of which rapidly became CDla-cells also appeared, and their number decreased CDla+, emerged from the CD13" population (Fig 5) . over time. Most sorted CD13"CDla-cells became CDla+ CD13hi cells were next sorted on day 12 according to in culture (Fig 6) , with the overall number of cells then CDla expression. Upon sorting, most CD13"CDla+ cells remaining stable in culture. Few of them initially had the had a typical DC morphology (data not shown). They reaspect of DCs, but typical DCs as well as adherent macro-" use only. CDla -.
phages emerged from this population after culture (data not shown). Altogether, these data suggest the occurrence of a differentiation pathway from CD1 3'" to CD 13"CD la-and to CD1 3hiCD 1 a+ cells. The CD 1 3hiCD la-cells presumably comprise common precursors to DCs and to macrophages, as already sugge~ted.~.'~.'~ It also appears from these results that the CDla+ cell number decrease noted after 12 days in bulk culture was probably due to the different life span of CDla+ relative to CDla-cells in relation with the culture conditions and perhaps the influence of other cell types, rather than to loss of CDla expression. 12. To test these hypotheses and because L 4 has been reported both to inhibit macrophage differentiation and to promote DC maturation from blood precursor^^'^^^^^^^^^ which might be akin to the CD13h'CDla-cells described here, we examined the effect of adding huIL-4 to cultures starting from day 12.
Effect of the addition of huIL-4 to the cultures afer day
This led to the appearance of morphologic changes of cultured cells, complete inhibition of adherent cell development, and an increase in the number and size of typical clusters of veiled cells, but without modifying cell numbers (Fig 7) . 
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As shown in Fig 8, which depicts a representative FACS analysis of day-20 cells, the use of huIL-4 led to increase of the "large" cell population on the average from about 50% to 80%; the proportion of CDla" cells with greater CDla and lower CD14 expression levels increased from about 20% to 70%, whereas that of CD14+CDla-cells decreased from 41% to 10%.
When day-l2 CD13hiCDla-cells sorted from CD13hi CDla+ cells were further cultured with huIL-4 after 6 days, all cells had become CDla+ in the presence of huIL-4, compared with about half in its absence (Fig 6) . This confirms that day-l2 CD13hiCDla-cells still contain DC precursors, from which huIL-4 is able to promote DC differentiation, as reported for blood DC precursors.21,22
Capacity of the cultured cells to stimulate the MLR. To further characterize the cells obtained under different culture conditions in our system, we examined their capacity to stimulate allogeneic adult T lymphocytes in the MLR.
First, day-l2 cells cultured with the different combinations of growth factors were irradiated and added in increasing amounts to 5 X IO4 allogeneic blood MNCs. The MLRstimulating capacity of cells cultured with huGM-CSF and huTNF-a was about 10-fold greater (P < .05; two-way analysis of variance) than that of cells cultured with huGM-CSF alone (Fig 9A) , as reported,I9s2' whereas cells grown in the additional presence of huSCF for the first 5 days of culture had comparable to fivefold greater MLR-stimulatory capacity ( P < .05) than when huSCF had not been added ( Fig   9B) . Also, day-20 cells grown in the presence of huIL-4 had twofold to fivefold greater ( P < .OS) stimulating capacity than without huIL-4 ( Fig 9C) .
We next determined that the MLR-stimulating capacity of cultured day-l2 cells in suspension was about 210-fold greater ( P < .01) than that of the corresponding cord blood adherent macrophages grown under the same conditions ( Fig  9D) . Nonetheless, comparing day-l2 sorted CD13hiCD1a+ versus CD13hiCDla-cells showed that, even though both cell types stimulated the MLR, CDla+ cells elicited the strongest ( P < .05) response (Fig 9E) . These results are consistent with prior findings that DCs have greater MLRstimulatory capacity than do monocyte/macrophages4~7~'9~20~31 and that CDla is expressed on more mature DCs that display the strongest antigen-presenting c a p a~i t y . '~,~~
DISCUSSION
DCs were initially recognized in the mouse and later in humans? Actually, they represent a broad class of ubiquitous cells,3." which results in a phenotypic diversity, albeit with common morphologic and functional characteristics such as a superior antigen-presenting capa~ity.'.~*'~ Therefore, the different methods and culture conditions that have been used to obtain DCs, especially from the peripheral blood, do not usually result in fully homogeneous populations, which may account for some of the disparate findings reported as to Nonetheless, some common phenotypic patterns appear for these cells.7~'2~15~'6~'s~20~22.25~33~34 They are CD33 myeloid cells that constitutively strongly express major histocompatibility class LT HLA-DR, -DP, and -DQ molecules and costimulatory molecules CD40, CD80, and CD86. CDla expression, which is considered a hallmark DC marker:3s35 seems in fact to be restricted to LCs, to interdigitating cells of lymphoid organs, and to blood DCs that have matured after in vitro culture. There are still discrepancies as regards expression of CD14, CD4, and adhesion molecules.7*16.33.36. 37 Questions remain as to the antigen-presenting capability of these cells according to the differentiation stage,337338 although it has been shown in mice that maturation of LCs into interdigitating DCs upon migration to lymph nodes corresponds to a process that is associated with reduced antigenprocessing capacity and enhanced antigen-presenting funct i~n .~~" ' Different cytokines, mainly GM-CSF but also TNF-a and SCF, play an important role in the maturation of DCs from hematopoietic progenitor^.'^-^^.^^*^' We used here combinations of these cytokines to generate DCs in vitro from puri- A major population of nonadherent mostly large granular cells, characterized by CD13hi expression, was individualized after a few days. CDla+ cells with characteristic DC morphology continuously emerged from this CD13hi population, at least during the first 2 weeks of culture, at which time they represented 20% to 50% of cells in suspension. At variance with other reports:o all CD13b cells, whether CDla+ or not, also expressed variable levels of CD14, which is thought to be macrophage lineage-speciti~?~ and these levels increased during the third week of culture, whereas the percentage of CDla+ cells decreased. However, these cells did not express macrophage markers such as nonspecific esterase activity or phagocytosis. Moreover, adding huL-4 to cultures at that time led to decreased CD14+ and increased CDlaf cell percentages, with upregulated CDla and downregulated CD14 expression, which is in line with the fact that DCs can be generated from human peripheral blood precursors cultured with GM-CSF and IL-4.2122
Analysis of the cells' allogeneic T-lymphocyte-stimulating capacity c~nfirmed~.~*~'.~' that DCs stimulated the MLR more than macrophages and that CDla+ cells, which should correspond to more mature DCs, were the strongest.'22032 The observed differences in MLR activity were smaller than expected, which could be due to the fact that peripheral blood mononuclear cells (PBMCs) instead of purified T cells were used as responder cells. The augmented stimulating capacity of day-20 cells cultured with huIL-4 did not account for the threefold greater proportion of CDla+ cells noted then. Culturing cells with huSCF for 5 days, without apparently affecting their subsequent phenotype, could increase their MLR-stimulating ability 1 week later. Although none of the investigated adhesiodcostimulatory molecules was affected by either growth factor (data not shown), this could indicate that expression of other accessory molecules not examined here was then modified or that the cytokine production pattern of these cells was then different.
Together, these results allow us to delineate a DC differentiation pathway from CD34+ progenitors to CD34-precursors that is characterized by increased CD13, CD4, and DR expression, from which DCs mature by acquiring CDla and use only. stimulating cells/well adhesion and costimulatory molecules. Because both typical DCs and macrophages could arise in culture from purified CD13h'CDla-cells, distinct precursors may possibly coexist among this population or CD13h' precursors may rather be common to the DC and macrophage lineages, as suggested by previously reported results of colony At any rate, one may consider that DC precursors differentiate in vitro first into CDla-cells close to peripheral blood DCs and then to CDla' cells, close to skin LCs, or interdigitating cells of lymphoid organs.2~""~14~'517. 23 To more precisely define DC differentiation requires using colony and limiting dilution assays, which are currenly under way in our laboratory. Nevertheless, the present results pro- vide the basis to intervene at defined stages of the DC differentiation pathway, and the fact that, in the system developed here, DCs express CD4 from their earlier stage on, makes it a useful tool with which to investigate DC interactions with human immunodeficiency 
